| Year |
Citation |
Score |
| 2018 |
Rolig AS, Sweeney EG, Kaye LE, DeSantis MD, Perkins A, Banse AV, Hamilton MK, Guillemin K. A bacterial immunomodulatory protein with lipocalin-like domains facilitates host-bacteria mutualism in larval zebrafish. Elife. 7. PMID 30398151 DOI: 10.7554/eLife.37172 |
0.524 |
|
| 2017 |
Burns AR, Miller E, Agarwal M, Rolig AS, Milligan-Myhre K, Seredick S, Guillemin K, Bohannan BJM. Interhost dispersal alters microbiome assembly and can overwhelm host innate immunity in an experimental zebrafish model. Proceedings of the National Academy of Sciences of the United States of America. PMID 28973938 DOI: 10.1073/Pnas.1702511114 |
0.676 |
|
| 2017 |
Rolig AS, Mittge EK, Ganz J, Troll JV, Melancon E, Wiles TJ, Alligood K, Stephens WZ, Eisen JS, Guillemin K. The enteric nervous system promotes intestinal health by constraining microbiota composition. Plos Biology. 15: e2000689. PMID 28207737 DOI: 10.1371/Journal.Pbio.2000689 |
0.655 |
|
| 2015 |
Rolig AS, Parthasarathy R, Burns AR, Bohannan BJ, Guillemin K. Individual Members of the Microbiota Disproportionately Modulate Host Innate Immune Responses. Cell Host & Microbe. 18: 613-20. PMID 26567512 DOI: 10.1016/J.Chom.2015.10.009 |
0.676 |
|
| 2014 |
Jemielita M, Taormina MJ, Burns AR, Hampton JS, Rolig AS, Guillemin K, Parthasarathy R. Spatial and temporal features of the growth of a bacterial species colonizing the zebrafish gut. Mbio. 5. PMID 25516613 DOI: 10.1128/Mbio.01751-14 |
0.674 |
|
| 2014 |
Guillemin K, Rolig AS. A twist in the tail. Elife. 3: e02386. PMID 24596155 DOI: 10.7554/Elife.02386 |
0.365 |
|
| 2013 |
Rolig AS, Cech C, Ahler E, Carter JE, Ottemann KM. The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota. Infection and Immunity. 81: 1382-9. PMID 23429529 DOI: 10.1128/Iai.00044-13 |
0.627 |
|
| 2012 |
Rolig AS, Shanks J, Carter JE, Ottemann KM. Helicobacter pylori requires TlpD-driven chemotaxis to proliferate in the antrum. Infection and Immunity. 80: 3713-20. PMID 22802346 DOI: 10.1128/Iai.00407-12 |
0.612 |
|
| 2011 |
Rolig AS, Carter JE, Ottemann KM. Bacterial chemotaxis modulates host cell apoptosis to establish a T-helper cell, type 17 (Th17)-dominant immune response in Helicobacter pylori infection. Proceedings of the National Academy of Sciences of the United States of America. 108: 19749-54. PMID 22106256 DOI: 10.1073/Pnas.1104598108 |
0.667 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Rolig AS, Sweeney EG, Kaye LE, DeSantis MD, Perkins A, Banse AV, Hamilton MK, Guillemin K. Author response: A bacterial immunomodulatory protein with lipocalin-like domains facilitates host–bacteria mutualism in larval zebrafish Elife. DOI: 10.7554/Elife.37172.034 |
0.297 |
|
| 2020 |
Walker JM, Rolig AS, Charych DH, Hoch U, Kasiewicz MJ, Rose DC, McNamara MJ, Hilgart-Martiszus IF, Redmond WL. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8 T cell responses capable of curing multi-focal cancer. Journal For Immunotherapy of Cancer. 8. PMID 32457127 DOI: 10.1136/Jitc-2019-000464 |
0.286 |
|
| 2020 |
Amani MF, Rolig AS, Redmond WL. Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8 T Cell Development. Journal of Immunology (Baltimore, Md. : 1950). PMID 32848035 DOI: 10.4049/Jimmunol.1901052 |
0.269 |
|
| 2018 |
Farhad M, Rolig AS, Redmond WL. The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. Oncoimmunology. 7: e1434467. PMID 29872573 DOI: 10.1080/2162402X.2018.1434467 |
0.265 |
|
| 2006 |
O'Connell KM, Rolig AS, Whitesell JD, Tamkun MM. Kv2.1 potassium channels are retained within dynamic cell surface microdomains that are defined by a perimeter fence. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9609-18. PMID 16988031 DOI: 10.1523/Jneurosci.1825-06.2006 |
0.227 |
|
| 2007 |
Tamkun MM, O'connell KM, Rolig AS. A cytoskeletal-based perimeter fence selectively corrals a sub-population of cell surface Kv2.1 channels. Journal of Cell Science. 120: 2413-23. PMID 17606996 DOI: 10.1242/Jcs.007351 |
0.22 |
|
| 2022 |
Rolig AS, Rose DC, McGee GH, Rubas W, Kivimäe S, Redmond WL. Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8 T cell cytotoxicity over BEMPEG+RT. Journal For Immunotherapy of Cancer. 10. PMID 35444059 DOI: 10.1136/jitc-2021-004218 |
0.191 |
|
| 2021 |
Sturgill ER, Rolig AS, Linch SN, Mick C, Kasiewicz MJ, Sun Z, Traber PG, Shlevin H, Redmond WL. Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity. Oncoimmunology. 10: 1892265. PMID 33717655 DOI: 10.1080/2162402X.2021.1892265 |
0.151 |
|
| 2021 |
Emerson DA, Rolig AS, Redmond WL. Enhancing the generation of Eomeshi CD8+ T cells augment the efficacy of OX40- and CTLA-4-targeted immunotherapy. Cancer Immunology Research. PMID 33593794 DOI: 10.1158/2326-6066.CIR-20-0338 |
0.141 |
|
| 2020 |
Amani MF, Rolig AS, Redmond WL. Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8 T Cell Development. Journal of Immunology (Baltimore, Md. : 1950). PMID 32848035 DOI: 10.4049/jimmunol.1901052 |
0.14 |
|
| 2022 |
Han M, Nguyen B, Lee JY, Browning E, Zhang J, Mukhopadhyay A, Gujar R, Salazar J, Hermiz R, Svenson L, Rolig AS, Redmond WL, Algazi AP, Daud AI, Canton DA, et al. Intratumoral electroporation of plasmid encoded IL-12 and membrane-anchored anti-CD3 increases systemic tumor immunity. Molecular Cancer Research : McR. PMID 35302641 DOI: 10.1158/1541-7786.MCR-21-0834 |
0.138 |
|
| 2023 |
Rose DC, Rolig AS, Redmond WL. Characterization of murine lymphocyte activation and exhaustion markers by a 14-color flow cytometry panel. Bioanalysis. PMID 37125902 DOI: 10.4155/bio-2023-0005 |
0.121 |
|
| 2021 |
Badeaux MD, Rolig AS, Agnello G, Enzler D, Kasiewicz MJ, Priddy L, Wiggins JF, Muir A, Sullivan MR, Van Cleef J, Daige C, Vander Heiden MG, Rajamanickam V, Wooldridge J, Redmond WL, et al. Arginase therapy combines effectively with checkpoint blockade or agonist anti-OX40 immunotherapy to control tumor growth. Cancer Immunology Research. PMID 33500272 DOI: 10.1158/2326-6066.CIR-20-0317 |
0.119 |
|
| 2021 |
Curti BD, Koguchi Y, Leidner RS, Rolig AS, Sturgill ER, Sun Z, Wu Y, Rajamanickam V, Bernard B, Hilgart-Martiszus I, Fountain CB, Morris G, Iwamoto N, Shimada T, Chang S, et al. Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor. Journal For Immunotherapy of Cancer. 9. PMID 33837055 DOI: 10.1136/jitc-2021-002371 |
0.075 |
|
| Hide low-probability matches. |